This club drug could alleviate severe depression in as little as 2 hours

When it comes to coping with severe depression, many patients are prescribed standard antidepressants like Prozac or Wellbutrin. But for those who are among the roughly 30 percent of depressed patients who don't respond to standard antidepressants, the situation is far more dire.
An in-depth report from Bloomberg details how the club drug ketamine — known on the street as Special K — could be useful in alleviating severe depression in patients who have had little success with more traditional drugs. Though ketamine hasn't been approved by the FDA, Bloomberg discusses multiple studies and real-life anecdotes that seem to indicate that ketamine "works by producing long-lasting changes in the brain, reversing neural damage caused by stress and depression, and potentially decreasing inflammation and cortisol levels." Furthermore, while traditional medication can take weeks or even months to take effect, many patients who receive ketamine infusions feel some relief in mere hours.
"It was the moment of my life," Dennis Hartman, who had already scheduled his suicide when he decided to try ketamine infusions, told Bloomberg. "Within a few hours I could tell that my anxiety and depression were completely gone for the first time in my memory."
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
While the drug undoubtedly comes with risks and doesn't work for everyone, clinics are popping up across the nation and companies are working to develop what Bloomberg says would be "similar, patentable drugs." "When it works," New Jersey psychiatrist Steven Levine told Bloomberg, "it's tremendous, it's wonderful."
Read the story in full at Bloomberg.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
-
The best body horror movies of the last half-century
The Week Recommends If 'The Substance' piqued your interest, these other films will likely be your speed
By Theara Coleman, The Week US Published
-
Why are CEOs having second thoughts about Trump?
Today's Big Question Tariff threats and economic warning signs create corporate uncertainty
By Joel Mathis, The Week US Published
-
Why Japanese residents can’t watch their country’s Oscar-nominated #MeToo documentary
THE EXPLAINER Shiori Ito became one of the faces of Japan's #MeToo movement. Her documentary about that experience, 'Black Box Diaries,' is up for an Academy Award, even as it struggles to be screened back home.
By Rafi Schwartz, The Week US Published
-
Texas outbreak brings 1st US measles death since 2015
Speed read The outbreak is concentrated in a 'close-knit, undervaccinated' Mennonite community in rural Gaines County
By Rafi Schwartz, The Week US Published
-
Mystery illness spreading in Congo rapidly kills dozens
Speed Read The World Health Organization said 53 people have died in an outbreak that originated in a village where three children ate a bat carcass
By Peter Weber, The Week US Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
California declares bird flu emergency
Speed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
By Rafi Schwartz, The Week US Published